logo-loader
viewAbattis Bioceuticals

Abattis extends gains on Experion share deal

medical_350_535030ad63437.jpg

Abattis Bioceuticals Corp. (OTCMKTS:ATTBF), a Canadian specialty biotechnology company, extended gains fueled in part by last week's announcement that Abattis has entered into a share exchange agreement with Experion Biotechnologies Inc.

The shares jumped 9.8 percent to $1.17 at 3:23 p.m. Eastern Time. 

The share volume had soared yesterday, with 1,166,632 changing hands, significantly higher than its three-month average.

Experion and Abattis’ wholly owned subsidiary Northern Vine have exchanged 25 percent of each parties' issued and outstanding common shares, Vancouver-based Abattis said in a statement on April 10. Abattis maintains a 75 percent ownership in Northern Vine.

Experion is located in Greater Vancouver and is nearing the completion of its Marijuana for Medical Purposes Regulations (MMPR) license application with Health Canada. 

Together, Northern Vine and Experion are well positioned to capitalize on the growing trend towards marijuana legalization in the U.S., and medical use in Canada as licensed producers, Abattis said last week.

Northern Vine, a lab and compounding pharmacy with patented compositions, owns various Natural Health Product licenses for use in the nutraceutical markets. 

Northern Vine has one remaining outstanding item to complete as required by Health Canada in respect of its controlled substance license application.

Abattis has surged twelve times in the past three months, giving the company a market value of $11.5 million.

 

Quick facts: Abattis Bioceuticals

Price: - CAD

CSE:ATT
Market: CSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Sativa Group signs significant product listing with WH Smith...

Sativa Group (Nex: SATI) CEO Henry Lees-Buckley dropped into the Vancouver studio of Proactive with news the company has signed a major CBD product listing agreement with WH Smith Travel.  Lees-Buckley talks about just how big that deal is and what he has been hearing from customers...

9 hours, 12 minutes ago

2 min read